Madhav Vissa, MD

I am a pediatric hematologist with a special interest in caring for individuals with inherited blood disorders, specifically sickle cell disease and thalassemia, throughout the lifespan. Before my fellowship training in pediatric hematology/oncology, I completed a residency in combined internal medicine and pediatrics with the goal of providing specialty care for individuals with lifelong medical conditions. My overarching goal is to ensure patients who live with chronic conditions are able to thrive as healthy, functional children, adolescents and adults. I aim to achieve this by providing excellent clinical care, engaging in clinical research to better understand the current state and future of care and care delivery, and continue to learn by teaching others about the complexities of these fascinating hematologic conditions.
Education
Fellowship, 06/2021 - Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital Oakland
Chief Residency, 06/2018 - Internal Medicine and Pediatrics, University of Pittsburgh Medical Center
Internship and Residency, 06/2018 - Internal Medicine and Pediatrics, University of Pittsburgh Medical Center
MD, 05/2014 - Medicine, SUNY Downstate Medical Center

  1. Vissa M, Larkin SK, Vichinsky EP, Kuypers FA, Soupene E. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. Experimental biology and medicine (Maywood, N.J.) 2023. PMID: 36941786


  2. Vissa M, Vichinsky E. Voxelotor for the treatment of sickle cell disease. Volume 14 of Issue 3. Expert review of hematology 2021. PMID: 33602029


  3. Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, Ingraham H, Higham C, Dvorak CC, Duncan C, Schoettler M, Lehmann L, Cancio M, Killinger J, Davila B, Phelan R, Mahadeo KM, Khazal S, Lalefar N, Vissa M, Myers K, Wallace G, Nelson A, Khandelwal P, Bhatla D, Gloude N, Anderson E, Huo J, Roehrs P, Auletta JJ, Chima R, Lane A, Davies SM, Jodele S. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood advances 2021. PMID: 33570619


  4. Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019. PMID: 31199983


  5. Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center. Volume 64 of Issue 8. Pediatric blood & cancer 2017. PMID: 28067012


  6. Blauel ER, Grossmann LT, Vissa M, Miller ST. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy. Volume 37 of Issue 7. Journal of pediatric hematology/oncology 2015. PMID: 26207780